Navigation Links
Bioness Inc Announces Availability of L300 Plus System
Date:8/29/2011

VALENCIA, Calif., Aug. 29, 2011 /PRNewswire/ -- Bioness Inc., today announced the commercial release of its NESS L300® Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300® Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.

The L300 Plus is intended for people living with neurological conditions resulting from stroke, multiple sclerosis, traumatic brain injury and spinal cord injury. The L300 Plus also helps to facilitate muscle re-education, prevent muscle atrophy, increase range of motion and increase local blood flow.

Sheltering Arms Physical Rehabilitation Centers located in Richmond, Va. is the first rehabilitation center in the country to offer the L300 Plus. According to James E. Sok, President and CEO, "The L300 Plus is a welcomed addition to our iWalk program which empowers our patients by offering a wide-range of technology-based therapy solutions. We are excited to offer leading rehab technologies in combination with our highly trained therapists to help restore function in our patients as they reintegrate back into the community."  

"For individuals living with central nervous system disorders, lack of mobility can be a challenging and life-altering issue," said Todd Cushman, Senior Vice President of Global Sales, Business Development and Marketing for Bioness. "With the L300 Plus, we aim to provide the more than 150,000 physical therapists and 3,200 neurorehabilitation clinics in the United States another option for helping neurological patients with gait disorders."

The L300 Plus is now commercially available to neurorehabilitation hospitals and centers around the country, and to consumers for home use.

For more information about the Bioness L300 Plus System and other Bioness devices, please call 800.211.9136 Option 2, or visit www.bioness.com.

About Bioness Inc.

Bioness provides neuromodulation technologies that help improve lives and restore function for those living with neurological deficits and peripheral pain. The Company designs and markets innovative neuromodulation products that help individuals with central nervous system disorders such as stroke, multiple sclerosis, spinal cord injury and traumatic brain injury regain movement in affected limbs. The NESS L300® Foot Drop System, NESS H200® Hand Rehabilitation System, and NESS L300® Plus System are cleared for use by the Food and Drug Administration and may help patients achieve new levels of physical independence and productivity.

Individual results vary. Consult with a qualified physician to find out if these products are right for you. Additional information about Bioness can be found at www.bioness.com.

NESS®, NESS H200®, NESS L300®, NESS L300® Plus, Bioness® are trademarks of Bioness Inc. | www.bioness.com | Rx Only

Media Contact:

Wendy Ryan/Genevieve Gadenne
Schwartz Communications
781-684-0770
bioness@schwartzcomm.com


'/>"/>
SOURCE Bioness Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bioness Inc. Receives FDA Clearance of Its NESS L300 Plus System
2. Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program
3. Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility
4. Masters Pharmaceutical, Inc. Announces DEA Registration for New Distribution Center
5. Life Extension® Announces Recruitment for Alzheimers Clinical Trial in South Florida
6. PDI Announces Renewal of Engagement for 7th Consecutive Season
7. Nutrastar Announces Adoption of Share Repurchase Program
8. ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
9. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock
10. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
11. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016 According to responses from ... than one-third (38%) of patients with non-small cell lung cancer ... factor receptor (EGFR) genetic mutation status. The findings of the ... LBA ID #6067 #P3.02b ) at the 2016 World ... . The survey results revealed an overall ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
(Date:12/7/2016)... Today, Stock-Callers.com presents four Biotech equities ... ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ), ProNAi ... (NASDAQ: AVXS ). From its peak in July ... reach a level equal to what it saw at the ... for the year, it has still out-performed other market sectors, ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... Norwalk, CT (PRWEB) , ... December 07, 2016 ... ... the Integrated Infertility and Wellness (IFW) Program at Reproductive Medicine Associates of Connecticut ... which now has a team of three acupuncturists to help patients realize their ...
Breaking Medicine News(10 mins):